OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines
Ruiqing He, Jie Zang, Yuge Zhao, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 2, pp. 406-423
Closed Access | Times Cited: 19

Showing 19 citing articles:

Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy
Yiming Xia, Shunli Fu, Qingping Ma, et al.
Nano-Micro Letters (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 52

Polymeric nanoparticle-based nanovaccines for cancer immunotherapy
Yongxin Zhang, Jiajing Chen, Linqi Shi, et al.
Materials Horizons (2022) Vol. 10, Iss. 2, pp. 361-392
Closed Access | Times Cited: 50

mRNA Cancer Vaccines: Construction and Boosting Strategies
Xiaoqing Liu, Pei Huang, Rusen Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19550-19580
Closed Access | Times Cited: 38

Reprogramming of sentinel lymph node microenvironment during tumor metastasis
Yen-Liang Li, Wen‐Chun Hung
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 37

Nano-Oncologic Vaccine for Boosting Cancer Immunotherapy: The Horizons in Cancer Treatment
Chao Chen, Yue‐Ping Xu, Hui Meng, et al.
Nanomaterials (2025) Vol. 15, Iss. 2, pp. 122-122
Open Access

Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons
Gamaleldin I. Harisa, Abdelrahman Y. Sherif, Fars K. Alanazi
The Journal of Membrane Biology (2023) Vol. 256, Iss. 3, pp. 199-222
Open Access | Times Cited: 10

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Fars K. Alanazi, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 15

Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy
Dandan Wang, Wenxing Gu, Weiliang Chen, et al.
Coordination Chemistry Reviews (2022) Vol. 472, pp. 214788-214788
Closed Access | Times Cited: 12

Lipid‐Based Nanoparticles
Sunny Shah, Hardik Madhu, Moinuddin Soniwala, et al.
(2024), pp. 241-273
Closed Access | Times Cited: 2

Drug delivery to the lymphatic system: The road less travelled
Annamalai Rama, Induja Govindan, Anjana A. Kailas, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access | Times Cited: 1

Advanced Strategies for Strengthening the Immune Activation Effect of Traditional Antitumor Therapies
Jingyi Ning, Xinxin Lu, Jianhui Dong, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 4701-4715
Closed Access | Times Cited: 1

Nanomedicine for Targeting Delivery of Gene and Other DNA / RNA Therapies Based Viruses Engineering
Xiangrong Song, Mengran Guo, Zhongshan He, et al.
Nanomedicine (2024), pp. 197-206
Closed Access

Effect of drugs of various groups on the pharmacokinetics of cefotaxime in comparison with their effect on lymphatic tissue drainage
German V. Kukushkin, L. P Sviridkina
Regional blood circulation and microcirculation (2024) Vol. 23, Iss. 3, pp. 89-95
Open Access

Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy
Mayumi Niimura, Yasuhisa Sakamoto, Mayuko Shimoda, et al.
Research Square (Research Square) (2024)
Open Access

Page 1

Scroll to top